Difficulty: Medium
Average Score: 94%
Practice
A patient is being treated with raloxifene (Evista) for osteoporosis. What should the nurse teach the patient about this medication?
Correct answer
C
Rationale
The correct answer is C. Raloxifene is a selective estrogen receptor modulator (SERM) used to prevent bone loss. It should be taken with food to reduce gastrointestinal side effects, not on an empty stomach. Choices A and B are incorrect because raloxifene is indeed a SERM that prevents bone loss, but it does not directly work by increasing bone formation or decreasing bone resorption. Choice D is incorrect as weight gain and fluid retention are not common side effects of raloxifene.